FDA inspection
Fairview Compounding Phamacy: FDA inspection ending Apr 18, 2018
FDA inspection 1048624 · Referred to State (RTS) · Minneapolis, MN
Key facts
| Inspection ID | 1048624 |
|---|---|
| Firm | Fairview Compounding Phamacy |
| FEI number | 3013468187 |
| Address | 711 Kasota Ave SE |
| City | Minneapolis |
| State | MN |
| ZIP | 55414-2842 |
| Fiscal year | 2018 |
| Inspection end date | Apr 18, 2018 |
| Classification | Referred to State (RTS) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data